Advertisement
All packs of Auvi-Q injectors are being recalled in the United States as some may not deliver the correct dose of epinephrine

Sanofi Recalls Auvi-Q Injectors Used to Treat Anaphylaxis

0
Injectors may not deliver right amount of drug
The melanoma drug Yervoy (ipilimumab) can now be used to reduce the risk of the recurrence after surgery

FDA Approves Expanded Use for Melanoma Drug

0
Yervoy can now be used after surgery to reduce risk of skin cancer returning
Human papillomavirus vaccination rates among American girls remain too low

CDC: Not Enough Young Girls Getting HPV Vaccination

0
Need to increase delivery of the vaccine at the recommended ages of 11 or 12 years
In patients with myofascial pain syndrome

Lidocaine, Hyaluronidase Mix Works Faster in Myofascial Pain

0
Findings following trigger point injections for treatment of myofascial pain syndrome
Cancer-associated incidental pulmonary embolism should be treated with low molecular weight heparins

Review Supports LMWH for Cancer-Linked Incidental PE

0
VTE recurrence risk similar under LMWHs, vitamin K antagonists; risk of major hemorrhage up under VKA
For patients with liver cirrhosis

Low-Dose Rifaximin Cuts Endotoxin Level in Cirrhosis

0
Similar reduction in serum endotoxin level for low-dose, high-dose rifaximin
For patients with rheumatoid arthritis and inflammatory bowel disease with prior nonmelanoma skin cancer (NMSC)

Some RA Treatments Up Second Nonmelanoma Skin Cancer Risk

0
Increased risk with methotrexate, and for anti-TNF drugs in conjunction with methotrexate
For patients with acute myocardial infarction

Part D Enrollment Doesn’t Improve Outcomes After AMI

0
Half of AMI patients enrolled in Part D by hospital discharge; outcomes no better than non-enrollees
For black patients with asthma treated with inhaled corticosteroids

LABAs No Better Than Tiotropium in Black Adults With Asthma

0
Outcomes similar for patients treated with inhaled corticosteroids plus tiotropium versus LABAs
A considerable proportion of federal marketplace plans lack at least one in-network specialist

Nearly 15 Percent of Plans Lack In-Network Specialists

0
Most commonly excluded specialists are in endocrinology, rheumatology, and psychiatry